Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2005
09/08/2005US20050196435 Encapsulating drug; drug delivery
09/08/2005US20050196434 Pharmaceutical composition and method for the transdermal delivery of magnesium
09/08/2005US20050196433 Delivery mechanism for magnesium which alleviates the disadvantages associated with the oral administration of magnesium supplements; magnesium chloride, zinc chloride, pluronic lecithin organogel, vitamin B6; diabetes, hypertension, high cholesterol, cardiac arrhythmias, acute myocardial infarction
09/08/2005US20050196428 Dilute aqueous solution containing epidermal growth factor in gel
09/08/2005US20050196424 Medical devices and methods for producing the same
09/08/2005US20050196421 Preventing surgical adhesions, by delivering a tissue-reactive polymer, then a fibrosis-inhibiting agent to the coated tissue
09/08/2005US20050196417 Taste masking complex of antihistamine and alginate
09/08/2005US20050196416 Dispersions prepared by use of self-stabilizing agents
09/08/2005US20050196410 Seaweed extract composition for treatment of inflammation
09/08/2005US20050196401 Energy-activated targeted cancer therapy
09/08/2005US20050196393 Add trisodium citrate to get cryoprecipitate without freezing plasma, without chromatography; single donors, limited pools; cryoprecipitate formed into a fibrin fabric; surgeries, wounds
09/08/2005US20050196382 Administering an oligonucleotide at least 10 nucleotides in length, whose antiviral activity occurs principally by a non-sequence complementary mode of action; especially for the prophylaxis treatment of cancer caused by oncoviruses
09/08/2005US20050196379 Combination therapies with L-FMAU for the treatment of hepatitis B virus infection
09/08/2005US20050196376 Simultaneously thickening and sterilizing medically useful cyanoacrylate oxygen free solution using precise ultraviolet radiation dose; simple, low cost, maintaining performance
09/08/2005US20050196374 Defecation deodorant
09/08/2005US20050196359 Method and composition for treating oral bacteria and inflammation
09/08/2005US20050196346 Micronized or spray dried solid active ingredient (oxitropium or tiotropium salts which are soluble in water), and coating consisting of fatty acid, alcohol derivative, and poloxamer
09/08/2005US20050196343 Degradable nanoparticles
09/08/2005US20050196341 Kit of parts for treating urinary incontinence in mammals
09/08/2005DE19956400B4 Therapeutisch wirksame Zusammensetzung, ein Verfahren zu ihrer Herstellung und ihre Verwendung Therapeutically effective composition, a process for their preparation and their use
09/08/2005DE102004017793A1 Use of trioxacarcins for treatment and prevention of infectious diseases, also new trioxacarcins for treatment of e.g. tumors, inflammatory and autoimmune diseases
09/08/2005DE102004009238A1 New aryl amide compounds are kinase inhibitors useful for the treatment and/or prophylaxis of e.g. tumors, psoriasis, rheumatoid arthritis, contact dermatitis, inflammations, endometriosis, scar and benign prostatic hyperplasia
09/08/2005DE102004009039A1 8-[3-Amino-piperidin-1-yl]-xanthine, deren Herstellung und Verwendung als Arzneimittel 8- [3-amino-piperidin-1-yl] -xanthines, their preparation and use as medicaments
09/08/2005DE102004008804A1 Mehrschichttablette Multilayer tablet
09/08/2005DE102004007966A1 Topische Zusammensetzung, enthaltend mindestens ein Aryloxim und Bisabolol Topical composition comprising at least one aryl oxime and bisabolol
09/07/2005EP1571203A2 Anti-inflammatory active principles in Euganean thermal mud
09/07/2005EP1571195A1 External composition containing highly unsaturated fatty acid or its salt or ester
09/07/2005EP1571154A1 Beta-aminoacid-derivatives as factor Xa inhibitors
09/07/2005EP1571152A1 Amorphous 3-Pyridil-1-Hydroxyethyliden-1,1-Biphosphonic acid monosodium salt and process for the preparation thereof .
09/07/2005EP1571147A2 Pyrazole analogs acting on cannabinoid receptors
09/07/2005EP1571146A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof
09/07/2005EP1571145A1 Substituted piperidine compounds for use as H3 histamine receptor antagonists
09/07/2005EP1571142A1 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
09/07/2005EP1571141A2 Naaladase inhibitors useful as pharmaceutical compounds and compositions
09/07/2005EP1571140A1 C-substituted cyclohexylmethylamine derivatives
09/07/2005EP1570871A1 Local vascular delivery of cladribine in combination with rapamycin to prevent restenosis following vascular injury
09/07/2005EP1570862A1 Highly soluble binary cyclodextrin inclusion complexes
09/07/2005EP1570861A2 Pharmaceutical compositions based on anticholinergically effective compounds and beta-mimetics
09/07/2005EP1570860A1 Antagonist and agonist binding to strong binding site of chemokine receptor
09/07/2005EP1570859A2 Improved treatment of neovascularization
09/07/2005EP1570852A2 Xenon for use as drug
09/07/2005EP1570851A1 Skin material for external use and antiprutiric agent for external use and wrinkle-reducing instrument using the same
09/07/2005EP1570850A1 Topical formulations for treatment of rosacea
09/07/2005EP1570849A1 Freeze-dried preparation of stabilized anthracycline compound
09/07/2005EP1570848A1 Treating postmenopausal women using ultra-low doses of estrogen
09/07/2005EP1570847A1 Phosphodiesterase 10a inhibitors
09/07/2005EP1570845A1 Remedy
09/07/2005EP1570844A2 Composition comprising pseudoephedrine and domperidone for preventing snoring
09/07/2005EP1570842A2 Composition containing chondroitin sulphate
09/07/2005EP1570840A2 Topical composition comprising n-acetylaldosamines or n-acetylamino acids
09/07/2005EP1570839A1 Composition for preparation for external use on skin and method of using the same
09/07/2005EP1570838A1 Dendrite elongation inhibitor for melanocyte and skin preparation for external use containing the same
09/07/2005EP1570837A1 Dendrite elongation inhibitor for melanocyte and skin preparation for external use containing the same
09/07/2005EP1570823A2 Substained analgesia achieved with buprenorphine
09/07/2005EP1570752A1 Verwendung von ungesättigten Fettsäuren zur Verringerung des Appetits oder der Essensaufnahme
09/07/2005EP1570751A1 Composition for the activation of the immune system
09/07/2005EP1570739A1 Antimicrobial composition containing N-(n-Butyl)-1, 2-Benzisothiazolin-3-One
09/07/2005EP1570262A1 Methods of measuring the dissolution rate of an analyte in a non-aqueous liquid composition
09/07/2005EP1570083A2 Identification of genes involved in angiogenesis, and development of an angiogenesis diagnostic chip to identify patients with impaired angiogenesis
09/07/2005EP1570069A2 Compositions and methods for cell dedifferentiation and tissue regeneration
09/07/2005EP1570067A2 Methods and compositions for immunization against hiv
09/07/2005EP1569951A2 Novel crystalline complexes
09/07/2005EP1569950A2 Plasmodium falciparum antigens and methods of use
09/07/2005EP1569939A1 Novel heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators
09/07/2005EP1569937A2 C-6 modified indazolylpyrrolotriazines
09/07/2005EP1569935A1 Heterocyclic compounds, preparation method thereof and use of same as medicaments, such as anti-bacterial medicaments and beta-lactamase inhibitors
09/07/2005EP1569933A1 Pyrrolidine and azetidine compounds as ccr5 antagonists
09/07/2005EP1569932A1 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
09/07/2005EP1569930A1 Indol derivatives and their use as 5-ht ligands
09/07/2005EP1569929A1 COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF i FLAVIVIRUS /i INFECTIONS
09/07/2005EP1569927A2 IMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
09/07/2005EP1569924A2 Nf-kb inhibitors
09/07/2005EP1569919A2 Non-nucleoside reverse transcriptase inhibitors
09/07/2005EP1569917A1 Pyrazine-based tubulin inhibitors
09/07/2005EP1569916A1 Substituted aralkyl derivatives
09/07/2005EP1569915A2 Spirocyclic ureas, compositions containing such compounds and methods of use
09/07/2005EP1569914A1 Pyrimidine-sulfamides and their use as endothelian receptor antagonist
09/07/2005EP1569904A1 Substituted arylalcanoic acid derivatives as ppar pan agonists with potent antihyperglycemic and antihyperlipidemic activity
09/07/2005EP1569903A2 Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myeloproliferative diseases
09/07/2005EP1569896A1 Tetrahydro-naphthalene derivatives
09/07/2005EP1569895A1 Prodrugs of gaba analogs, compositions and uses thereof
09/07/2005EP1569892A2 Calcilytic compounds
09/07/2005EP1569724A1 Formulations containing melatonin, ginkgo biloba, and biotin
09/07/2005EP1569723A2 Nucleotide based medicament and method of use for treatment of conditions in humans
09/07/2005EP1569696A2 Methods and immune modulatory nucleic acid compositions for preventing and treating disease
09/07/2005EP1569693A1 Pharmaceutical compositions having a modified vehicle
09/07/2005EP1569692A2 Betaine and salicylic acid compositions
09/07/2005EP1569682A2 Combination treatment using exendin-4 and thiazolidinediones
09/07/2005EP1569679A1 Chaperonin 10 immunosuppression
09/07/2005EP1569670A2 Flavanols and procyanidins promote homeostasis
09/07/2005EP1569669A2 Withania somnifera composition, method for obtaining same and pharmaceutical, nutritional and personal care formulations thereof
09/07/2005EP1569663A2 Ifosfamide compositions for parenteral administration and a process for their preparation
09/07/2005EP1569662A2 Treatment of neurodegenerative disease through intracranial delivery of short interfering rna (sirna)
09/07/2005EP1569661A2 Antisense design
09/07/2005EP1569660A2 C-type lectin binding molecules, identification and uses thereof
09/07/2005EP1569659A2 Dioxolane thymine and combinations for use against 3tc/ azt resistant strains of hiv
09/07/2005EP1569658A2 Treatment of ebv and khsv infection and associated abnormal cellular proliferation
09/07/2005EP1569657A1 Use of amphiphilic lipids for the preparation of a pharmaceutical composition for reducing tumor metastasis
09/07/2005EP1569656A2 Phosphoantigens for regulating an immune response
09/07/2005EP1569655A1 Use of selective progesterone receptor modulators for the treatment of androgen deficiency
1 ... 4551 4552 4553 4554 4555 4556 4557 4558 4559 4560 4561 4562 4563 4564 4565 4566 4567 4568 4569 4570 4571 ... 7860